Completion of Placement and Institutional Entitlement Offer
Filed with ASX · · 4 pages · English
• Adherium Limited (ASX: ADR) (“Adherium” or “the Company”), a global leader in digital respiratory management and developer of the US FDA-cleared Hailie® Smartinhaler® • The Company is pleased to announce that it has received firm commitments for a total of $6.70 million under the Placement and institutional component of the ANREO (Institutional Entitlement Offer) o Under the Placement, the Compa
Earlier from Adherium
- Placement and Accelerated Non-Renounceable Entitlement Offer
- Equity Raising Investor Presentation
- Trading Halt
- Quarterly Activities/Appendix 4C Cash Flow Report
- Adherium exceeds CY2025 device shipment milestones
Later from Adherium
- Half Yearly Report and Accounts
- Adherium Hailie Smartinhaler Quarter-to-Date Sales Update
- Notice of Share Consolidation
- Results of Extraordinary General Meeting
- Adherium - Investor Update
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium